Neurocrine Biosciences (NBIX) Change in Cash (2010 - 2026)
Neurocrine Biosciences (NBIX) posted Change in Cash of $64.4 million for Q2 2026, down 7.9% from $69.9 million a year earlier.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Change in Cash (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Change in Cash at Neurocrine Biosciences was $66.9 million, down 46.2% year-over-year; for FY2025, it was $480 million.
- Annual Change in Cash shows a five-year compound annual growth rate of 45.0% (FY2020 to FY2025).
- In prior years, Neurocrine Biosciences' Change in Cash was -$18.1 million in FY2024, -$11.6 million in FY2023, -$73.3 million in FY2022 and $153.7 million in FY2021 (+105.5%).
- Quarterly Change in Cash has run from a low of -$446.5 million in Q1 2026 to a high of $372.8 million in Q4 2025 over five years.
- According to Business Quant data, Change in Cash for the three prior quarters was -$446.5 million (Q1 2026), $372.8 million (Q4 2025) and $76.2 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -1.27 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -2.82 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.49 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 739.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -2.64 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.95 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -4.45 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -727.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 649.20 Mn |
| 10 | Neurocrine Biosciences | 14.41 Bn | 10.11 Bn | 935.80 Mn | 64.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 64.40 Mn |
| Mar 31, 2026 | -446.50 Mn |
| Dec 31, 2025 | 372.80 Mn |
| Sep 30, 2025 | 76.20 Mn |
| Jun 30, 2025 | 69.90 Mn |
| Mar 31, 2025 | -38.90 Mn |
| Dec 31, 2024 | -116.10 Mn |
| Sep 30, 2024 | 209.40 Mn |
| Jun 30, 2024 | -256.60 Mn |
| Mar 31, 2024 | 145.20 Mn |
| Dec 31, 2023 | -42.60 Mn |
| Sep 30, 2023 | 133.50 Mn |
| Jun 30, 2023 | 56.60 Mn |
| Mar 31, 2023 | -159.10 Mn |
| Dec 31, 2022 | 50.70 Mn |
| Sep 30, 2022 | 48.90 Mn |
| Jun 30, 2022 | -106.90 Mn |
| Mar 31, 2022 | -66.00 Mn |
| Dec 31, 2021 | 29.70 Mn |
| Sep 30, 2021 | -56.90 Mn |
API Access
Neurocrine Biosciences Change in Cash API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-cash&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-cash", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-cash&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();